Last reviewed · How we verify

NCT05336669: GlobalACT

Coagulation Profile in Patients Undergoing Coronary Angiography and Percutaneous Coronary Intervention

Status unknown Last updated 20 April 2022
What this trial tests

trial in Chronic Coronary Insufficiency in 40 participants. Status unknown.

Timeline
30 April 2022
Primary endpoint
31 August 2022
31 August 2023

Quick facts

Lead sponsorCentre of Postgraduate Medical Education
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment40
Start date30 April 2022
Primary completion31 August 2022
Estimated completion31 August 2023

Conditions studied

Sponsor

Centre of Postgraduate Medical Education — full company profile →

Who can join

Adults 18 to 100, any sex, with Chronic Coronary Insufficiency or Smoking. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The activated clotting time (ACT), global thrombosis test (GTT-3), platelet inhibition P2Y12 (VerifyNow) test and serum coagulation factors will be measured in patients undergoing coronary angiography (CA) and percutaneous coronary intervention (PCI).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Chronic Coronary Insufficiency

Currently open trials in the same condition.

Other Centre of Postgraduate Medical Education trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05336669.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing